Target
C-C motif chemokine 3
Ligand
BDBM50070114
Substrate
n/a
Meas. Tech.
cytomteric bead array (CBA) assay
Temperature
310.15±n/a K
IC50
>10000±n/a nM
Comments
extracted
Citation
 Gandhi, ADimartino, JChopra, R Methods for the treatment of locally advanced breast cancer US Patent  US9694015 Publication Date 7/4/2017 
Target
Name:
C-C motif chemokine 3
Synonyms:
CCL3 | CCL3_HUMAN | G0/G1 switch regulatory protein 19-1 | G0S19-1 | MIP-1-alpha | MIP1A | Macrophage inflammatory protein 1-alpha | PAT 464.1 | SCYA3 | SIS-beta | Small-inducible cytokine A3 | Tonsillar lymphocyte LD78 alpha protein
Type:
Protein
Mol. Mass.:
10083.38
Organism:
Homo sapiens (Human)
Description:
P10147
Residue:
92
Sequence:
MQVSTAALAVLLCTMALCNQFSASLAADTPTACCFSYTSRQIPQNFIADYFETSSQCSKPGVIFLTKRSRQVCADPSEEWVQKYVSDLELSA
  
Inhibitor
Name:
BDBM50070114
Synonyms:
(+/-)-thalidomide | 2-(2,6-Dioxo-piperidin-3-yl)-isoindole-1,3-dione | 2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione | CHEMBL468 | K-17 | THALIDOMIDE | Thalomid | US11059801, Compound D-62 | [(R,S)-2-(2,6-dioxo-3-piperidinyl)-1H-isoindole-1,3(2H)-dione
Type:
Small organic molecule
Emp. Form.:
C13H10N2O4
Mol. Mass.:
258.2295
SMILES:
O=C1N(C2CCC(=O)NC2=O)C(=O)c2ccccc12
Structure:
Search PDB for entries with ligand similarity: